Access to rehabilitation or other therapies for symptom management Rehabilitation or therapy available in country of interest? World Bank category Low income WHO region African Global results
% of countries reporting people can access rehabilitation or other therapies for each symptom
Fatigue No 33% 21% 59%
Heat sensitivity No 11% 0% 25%
Difficulty walking Yes 67% 64% 93%
Stiffness and spasms Yes 67% 71% 91%
Bladder problems No 33% 14% 73%
Memory and other cognitive problems No 22% 21% 57%
Pain and other unpleasant sensations Yes 56% 36% 77%
Emotional and mood problems Yes 33% 43% 69%
Vision problems Yes 33% 29% 52%
Dizziness or vertigo Yes 22% 43% 63%
Bowel problems Yes 11% 21% 56%
Tremors No 0% 7% 55%
Sexual problems No 11% 14% 51%
Difficulty moving arms/hands Yes 44% 64% 80%
Swallowing problems Yes 33% 36% 71%
Speech problems Yes 22% 43% 74%
Seizures Yes 11% 36% 60%
Not sure No 33% 29% 4%

What is the Atlas of MS?

The Atlas of MS is the most comprehensive worldwide study of the epidemiology of MS and the global availability and accessibility of resources for people with MS.

Explore the latest MS data

Access the latest Atlas of MS reports, infographics, slides and datasets to support research, advocacy and policy development. Planning an analysis or publication? Contact the Atlas team at [email protected] for guidance on methodology, data interpretation and related work.

Powerful tool for change

The information in the Atlas of MS can be a powerful advocacy tool, shining a spotlight on MS and raising awareness of the lack of adequate resources available to diagnose, inform, treat, rehabilitate and support people with MS worldwide.

With thanks to…

Worldwide collaboration

The Atlas of MS relies on data supplied by MS organisations from around the world. We are most grateful to the country coordinators and their colleagues for taking the time and effort to gather the information and data.

See contributor list

The Atlas of MS is one of the strongest examples of what the global MS movement can achieve through collaboration. By bringing together evidence from countries around the world, it helps inform policy, strengthen advocacy and guide future investment in research and healthcare. The Atlas also highlights the need for continued investment in surveillance, registries and data systems to strengthen our understanding of the true burden of MS. Better data lead to better decisions and, ultimately, better outcomes for people affected by MS worldwide.

Professor Mario Alberto Battaglia
Chair, MS International Federation (MSIF) and President of the Italian MS Society (Associazione Italiana Sclerosi Multipla [AISM])